Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
Clinical trial NCT03341806 · COMPLETED
Trial details
- NCT number
- NCT03341806
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-13
- Primary completion
- 2021-10-13
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.